Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - first steps towards gene therapy of Alport syndrome.

scientific article

Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - first steps towards gene therapy of Alport syndrome. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID8929908

P2093author name stringWeber M
Tryggvason K
Lukkarinen O
Parpala T
Heikkila P
P433issue1
P921main subjectAdenoviridaeQ193447
gene therapyQ213901
Alport syndromeQ1331116
P304page(s)21-27
P577publication date1996-01-01
P1433published inGene TherapyQ15763095
P1476titleAdenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - first steps towards gene therapy of Alport syndrome
P478volume3

Reverse relations

cites work (P2860)
Q24804413A new mouse model for renal lesions produced by intravenous injection of diphtheria toxin A-chain expression plasmid
Q50096202Adenovirus-mediated gene transfer to glomerular cells in newborn mice
Q38238367Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment
Q34577155An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer
Q38941236Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome
Q81692071Familial hematurias: what we know and what we don't
Q37670342Feasibility of repairing glomerular basement membrane defects in Alport syndrome
Q36691191Gene therapy targeting kidney diseases: routes and vehicles
Q37786559Gene therapy to the kidney using viral vectors
Q90093164Genetic Engineering of the Kidney to Permanently Silence MHC Transcripts During ex vivo Organ Perfusion
Q36842383Irradiation prolongs survival of Alport mice
Q39642143Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted
Q45871465Renal, auricular, and ocular outcomes of Alport syndrome and their current management
Q36295324Targeting gene expression to specific cells of kidney tubules in vivo, using adenoviral promoter fragments
Q42924514The 2014 International Workshop on Alport Syndrome.
Q33866177The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates
Q35791352Transfer of the alpha 5(IV) collagen chain gene to smooth muscle restores in vivo expression of the alpha 6(IV) collagen chain in a canine model of Alport syndrome
Q90293692Transplantation of umbilical cord mesenchymal stem cells into mice with focal segmental glomerulosclerosis delayed disease manifestation

Search more.